Although business headlines still tout earnings numbers, many investors have moved past net earnings as a measure of a company's economic output. That's because earnings are very often less trustworthy than cash flow, since earnings are more open to manipulation based on dubious judgment calls.
Earnings' unreliability is one of the reasons Foolish investors often flip straight past the income statement to check the cash flow statement. In general, by taking a close look at the cash moving in and out of the business, you can better understand whether the last batch of earnings brought money into the company, or merely disguised a cash gusher with a pretty headline.
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Adams Resources & Energy (AMEX: AE), whose recent revenue and earnings are plotted below.
Top 5 Gas Utility Stocks To Own For 2015: Imprimis Pharmaceuticals Inc (IMMY)
Imprimis Pharmaceuticals Inc. is a specialty pharmaceutical company developing non-invasive, topically delivered products. The Company�� Transdel cream formulation technology is designed to facilitate the effective penetration of a variety of products through the tough skin barrier. Ketotransdel, the Company�� lead pain product, utilizes the Transdel platform technology to deliver the active drug, ketoprofen, a non-steroidal anti-inflammatory drug (NSAID), through the skin directly into the underlying tissues where the drug exerts its anti-inflammatory and analgesic effects. Ketotransdel consists of a transdermal formulation of ketoprofen, a non-steroidal anti-inflammatory drug (NSAID), and its Transdel drug delivery system and is being developed for the treatment of acute pain. In July 2013, it acquired intellectual property for IPI-120 from Buderer Drug Company.
Ketotransdel penetrates the skin barrier to reach the targeted underlying tissues where it exerts its localized anti-inflammatory and analgesic effect. Transdel is the Company�� transdermal cream drug delivery platform. It consists of a cream that enables transdermal penetration of drugs avoiding first pass metabolism by the liver and minimizing systemic exposure. The Transdel drug delivery system facilitates the effective dissolution and delivery of a drug across the skin barrier to reach targeted underlying tissues.Advisors' Opinion:
- [By John Udovich]
The start of 2014 shows that biotech is still a hot area with the sector along with small cap biotech stocks like AMAG Pharmaceuticals, Inc (NASDAQ: AMAG), Mast Therapeutics Inc (NYSEMKT: MSTX), Cell Therapeutics Inc (NASDAQ: CTIC), Imprimis Pharmaceuticals Inc (NASDAQ: IMMY) and TNI BioTech (OTCMKTS: TNIB) producing news or returns�plus Auspex Pharmaceuticals (NASDAQ: ASPX), Cara Therapeutics (NASDAQ: CARA), Egalet (NASDAQ: EGLT), Flexion Therapeutics (NASDAQ: FLXN) and Ultragenyx Pharmaceutical (NASDAQ: RARE) are among the (many�� planned biotech IPOs that have recently been announced publicly:
Best Net Payout Yield Stocks To Own For 2014: V.F. Corporation(VFC)
V.F. Corporation designs and manufactures, or sources from independent contractors various apparel and footwear products primarily in the United States and Europe. The company offers apparel, footwear, outdoor gear, skateboard-inspired and surf-inspired footwear, backpacks, luggage, handbags and accessories, outdoor apparel, travel accessories, and women?s active wear primarily under the Vans, The North Face, JanSport, Eastpak, Kipling, Napapijri, Reef, Eagle Creek, and lucy brands; and denim and casual bottoms, and tops principally under Wrangler, Lee, Riders, Rustler, and Timber Creek by Wrangler brands. Its products also include occupational, athletic, and licensed apparel primarily under the Red Kap, Bulwark, Majestic, MLB, NFL, and Harley-Davidson brands; men?s fashion sportswear, denim bottoms, sleepwear, underwear, as well as handbags, luggage, backpacks, and accessories principally under the Nautica and Kipling brands; and denim and casual bottoms, sportswear, acce ssories, men?s apparel and footwear, and women?s sportswear primarily under the 7 For All Mankind, John Varvatos, Splendid, and Ella Moss brands. The company sells its products to specialty stores, department stores, national chains, and mass merchants primarily through its sales force, independent sales agents, and distributors. V.F. Corporation was founded in 1899 and is based in Greensboro, North Carolina.Advisors' Opinion:
- [By Ben Levisohn]
Shares of Ralph Lauren have gained 5.2% to $180.07 at 3:33 p.m. today, and they’ve even boosted other apparel companies. PVH (PVH) has gained 0.7% to $125.75, Hanesbrands (HBI) has advanced 1.3% to $68.25 and VF Corp. (VFC) is up 0.9% to $2221.78.
Best Net Payout Yield Stocks To Own For 2014: Celsion Corporation(CLSN)
Celsion Corporation, an oncology drug development company, develops and commercializes targeted chemotherapeutic oncology drugs based on its proprietary heat-activated liposomal technology. The company is developing its lead product, ThermoDox that is in Phase III clinical trial for primary liver cancer; and in phase II clinical trial for treatment of recurrent chest wall breast cancer. It has a license agreement with Yakult Honsha to commercialize and market ThermoDox for the Japanese market. The company also has a license agreement with Duke University under which it received exclusive rights to commercialize and use Duke's thermo-liposome technology. In addition, Celsion Corporation has a joint research agreement with Royal Phillips Electronics to evaluate the combination of Phillips' high intensity focused ultrasound with its ThermoDox to determine the potential of this combination to treat a range of cancers. The company was founded in 1982 and is based in Columbia, M aryland.Advisors' Opinion:
- [By EquityOptionsGuru]
The Prolieve Thermodilatation System was actually developed by the current management of Medifocus while employed at Celsion Corporation (NASDAQ:CLSN). The system was also jointly developed with Boston Scientific (NYSE:BSX) before being acquired by Medifocus in July 2012. Prolieve has already received FDA approval, is currently generating revenue, and is the only in office alternative to drug therapy. The system essentially uses microwave energy to treat Benign Prostatic Hyperplasia (BPH), which is a non-cancerous enlargement of the prostate gland that typically affects men over the age of 50. The Prolieve device works by compressing and heating prostatic tissue that may be blocking the flow of urine. This particular treatment option offers patients several benefits including the following:
- [By Paul Ausick]
Stocks on the Move: NQ Mobile Inc. (NYSE: NQ) is up 26% at $11.09 as the company fights back against a short-seller report. Celsion Corp. (NASDAQ: CLSN) is up 339.3% at $5.14 following a reverse 1:4.5 stock split. Micron Technology Inc. (NASDAQ: MU) is up 4.7% at $17.50.
Best Net Payout Yield Stocks To Own For 2014: CDW Corp (CDW)
CDW Corporation (CDW), incorporated on May 25, 2007, is a provider of integrated information technology (IT) solutions in the United States and Canada. Its range of offerings range from discrete hardware and software products to integrated IT solutions, such as mobility, security, data center optimization, cloud computing, virtualization and collaboration. The Company has two segments: Corporate and Public. Corporate segment consists of primarily of private sector business customers. Public segment consists of government agencies and education and healthcare institutions. CDW also has two other operating segments, CDW Advanced Services and Canada (combined together as Other). The Company is a sales channel partner for many original equipment manufacturers (OEMs) and software publishers (collectively, its vendor partners), whose products it sells or include in the solutions CDW offers. The Company helps its customer base of more than 250,000 small, medium and large business, government, education and healthcare customers by delivering solutions to their IT needs.
The Company�� Corporate segment is divided into a medium-large business customer channel, primarily serving customers with more than 100 employees, and a small business customer channel, primarily serving customers with up to 100 employees. The CDW Advanced Services business consists primarily of customized engineering services delivered by technology specialists and engineers and managed services that include infrastructure as a service (IaaS) offerings. The Company�� product portfolio includes more than 100,000 products from more than 1,000 brands. Revenues from the sale of hardware, software, custom configuration and third-party provided services are recorded within its Corporate and Public segments.
The Company�� revenue from professional services is either recognized as incurred for services billed at an hourly rate or recognized using a proportional performance model for services provided at a fixed fee.! Revenue from software as a service (SaaS) arrangements, IaaS arrangements, and data center services, including Internet connectivity, Web hosting, server co-location and managed services, is recognized over the period service is provided. The Company also sells certain products for which it acts as an agent. Products in this category include the sale of third-party services, warranties or software assurance (SA) or third-party-hosted SaaS and IaaS arrangements. The Company offer over 1,000 brands, from companies, such as APC, Apple, Cisco, EMC, Hewlett-Packard, IBM, Lenovo, Microsoft, NetApp, Symantec and VMware, to vendor partners, such as Drobo, Fusion-io, Meraki, Nimble Storage, Salesforce.com, Sophos and Splunk.
The Company competes with Dimension Data, ePlus, Insight Enterprises, PC Connection, PCM, Presidio, Softchoice, World Wide Technology, Dell, Hewlett-Packard, Apple, Amazon, Newegg, TigerDirect.com, Buy.com, IBM, Accenture, Staples, Office Depot and Office Max.Advisors' Opinion:
- [By Rich Smith]
Just over six years after leaving the public stock markets in a $7.3 billion leveraged buyout, IT equipment supplier CDW (NASDAQ: CDW ) is back on the Nasdaq again!
- [By Jon C. Ogg]
Before you consider this just to be a bit of IPO pondering, take a step back and understand that some of this list membership already has�filed to come public or actually has�made it public recently. Boise Cascade Co. (NYSE: BCC), CDW Corp. (NASDAQ: CDW), Coty Inc. (NYSE: COTY), Global Brass and Copper Holdings Inc. (NYSE: BRSS), Noodles & Company (NASDAQ: NDLS), Restoration Hardware Holdings Inc. (NYSE: RH), Sprouts Farmers Market Inc. (NASDAQ: SFM) and many others are on the list and have made it to the post-IPO stage in the stock market.
Best Net Payout Yield Stocks To Own For 2014: Bulova Technologies Group Inc (BTGI)
Bulova Technologies Group, Inc. (BLVT), incorporated in 1979, operates as a Government contractor in the United States. BLVT�� operating facilities are located in Mayo, Florida. As of September 30, 2011, the Company is focused on Department of Defense contracting. As of September 30, 2011, BLVT operated corporate and administrative offices in two leased facilities, one in Clearwater, Florida, approximating 2,400 square feet, and the other in Brandon, Florida, approximating 5,000 square feet. The Company�� Government contracting business is located on 261 acres owned by the Company in Mayo, Florida, where it operates a load, assembly, and pack facility specializing in fuzes, safe and arming devices and explosive simulators. There are more than 38 buildings on the property consisting of warehouses, storage, and manufacturing facilities. In March 31, 2011, the Company disposed of its subsidiary BT Manufacturing Company LLC. In October 2012, the Company sold Bulova Technologies Ordnance Systems LLC.
Bulova Technologies Ordnance Systems LLC is a load, assembly, and pack facility specializing in fuzes, safe and arming devices and explosive simulators. Bulova Technologies Ordnance Systems LLC produces a range of pyrotechnic devices, ammunition and other energetic materials for the United States Government and other allied Governments worldwide. Bulova Technologies (Europe) LLC is developing a mortar exchange program to facilitate the needs of NATO member countries.Advisors' Opinion:
- [By Peter Graham]
A quick look at Hybrid Coating Technologies��financials reveals revenues of $48k (most recent reported quarter), $5k, $3k and $53k for the past four reported quarters along with net losses of $821k (most recent reported quarter), $1,571k, $774k and $510. At the end of September, Hybrid Coating Technologies had no cash to cover $4,037k in current liabilities and $1,279k in long term debt. So while the global industrial and specialty coatings market might be worth $35 billion, Hybrid Coating Technologies has yet to grab enough of it.Bulova Technologies Group, Inc (OTCMKTS: BTGI) Recently Did a Reverse Split
Small cap Bulova Technologies Group has an extensive history of large scale Defense Contracts for munitions, weapons systems and combat systems. On Friday, Bulova Technologies Group fell 13.04% to $0.0300 for a market cap of $663,789 plus BTGI is up 29,900% over the past year and down 66.7% over the past five years according to Google Finance.